[
    [
        {
            "time": "2021-11-30",
            "original_text": "Merck Shares Fall Ahead of FDA Hearing on Covid Pill",
            "features": {
                "keywords": [
                    "Merck",
                    "Shares",
                    "Fall",
                    "FDA",
                    "Covid",
                    "Pill"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "Merck Shares Fall Ahead of FDA Hearing on Covid Pill",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-11-30",
            "original_text": "US STOCKS-Wall Street rebounds after virus-related sell-off",
            "features": {
                "keywords": [
                    "US",
                    "STOCKS",
                    "Wall",
                    "Street",
                    "rebounds",
                    "virus-related",
                    "sell-off"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "general market"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "US STOCKS-Wall Street rebounds after virus-related sell-off",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-11-30",
            "original_text": "Omicron stock market rout doesn't mean stocks are a 'screaming' buy: strategist",
            "features": {
                "keywords": [
                    "Omicron",
                    "stock",
                    "market",
                    "rout",
                    "strategist"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "general market"
                ],
                "causal_factor": "false",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Omicron stock market rout doesn't mean stocks are a 'screaming' buy: strategist",
                "Correlation": 5,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-11-30",
            "original_text": "Dow Jones Jumps 300 Points As Stock Market Rebounds From Friday Rout",
            "features": {
                "keywords": [
                    "Dow",
                    "Jones",
                    "Jumps",
                    "Stock",
                    "Market",
                    "Rebounds",
                    "Friday",
                    "Rout"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "general market"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Dow Jones Jumps 300 Points As Stock Market Rebounds From Friday Rout",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 10,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-11-30",
            "original_text": "BioNTech, Pfizer, J&J and Moderna Developing Omicron Vaccines",
            "features": {
                "keywords": [
                    "BioNTech",
                    "Pfizer",
                    "J&J",
                    "Moderna",
                    "Developing",
                    "Omicron",
                    "Vaccines"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "BioNTech, Pfizer, J&J and Moderna Developing Omicron Vaccines",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-11-30",
            "original_text": "Another COVID wave could depress consumer spending, labor force participation: Economist",
            "features": {
                "keywords": [
                    "COVID",
                    "wave",
                    "consumer",
                    "spending",
                    "labor",
                    "force",
                    "participation",
                    "Economist"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "economy"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "Another COVID wave could depress consumer spending, labor force participation: Economist",
                "Correlation": 5,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-11-30",
            "original_text": "Vaccine Stocks Could Win Now, Lose Later, From the Omicron Variant",
            "features": {
                "keywords": [
                    "Vaccine",
                    "Stocks",
                    "Win",
                    "Lose",
                    "Omicron",
                    "Variant"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Vaccine Stocks Could Win Now, Lose Later, From the Omicron Variant",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]